Shane Carter
Psychiatry · Murray, UTNPI 1245955822
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,716 of the $5,818 with a category attached, or 81.1%. 13 manufacturers reported payments, led by Neuronetics, Inc. at 32.2% of the total. Among psychiatry clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $37.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$2K
- AbbVie$1K
- Johnson & Johnson$929
- Otsuka America Pharmaceutical, Inc.$424
- Supernus Pharmaceuticals, Inc.$357
- E.r. Squibb & Sons, L.L.C.$338
- plus $754 from 7 others
What the payments were for
- Travel & lodging$1,09619%
- Food & beverage$4,71681%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 3 | $1,871 |
| AbbVie | 37 | $1,147 |
| Johnson & Johnson | 38 | $929 |
| Otsuka America Pharmaceutical, Inc. | 13 | $424 |
| Supernus Pharmaceuticals, Inc. | 20 | $357 |
| E.r. Squibb & Sons, L.L.C. | 17 | $338 |
| Braeburn Inc. | 5 | $296 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $148 |
| Lundbeck LLC | 6 | $123 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,818 in reported general payments places this provider in the 90th percentile of 231 psychiatry providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 28 | $37,020 |
| Aripiprazole | 24 | $979 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 33 | $613 |
| Guanfacine Hcl | 15 | $505 |
| Bupropion XlBupropion Hcl | 23 | $487 |
| Propranolol Hcl | 17 | $309 |
| Duloxetine Hcl | 24 | $307 |
| Alprazolam | 20 | $264 |
| Buspirone Hcl | 26 | $256 |
| Trazodone Hcl | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $929 | $37,02028 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 231 psychiatry providers in Utah.
Other psychiatry in Murray
- Scott SalomoneMurray$4K
- Michael MeasomSlc$2.2M
- Noel GardnerSalt Lake City$512K
- Reid RobisonOrem$133K
- Thomas RaynerProvo$60K
- Trent HolmbergDraper$32K
- Nathan CurrierRiverton$21K
- Oliver McPhersonBountiful$20K
- Frederick ReimherrSalt Lake City$18K
- Lisa FraleighLogan$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.